Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
R&D Systems Inc. is active in the Biotechnology & Pharmaceuticals technology area, where it currently manages a patent portfolio with 1 pending office action. This single active matter represents the current scope of the company's engagement with the patent office. The prosecution is localized within 1 distinct art unit, indicating that the pending application is being evaluated against a specific set of technical and legal standards.
The portfolio's current examination is conducted by 1 distinct examiner, which simplifies the coordination of the prosecution strategy. SWIFT, CANDICE LEE is the busiest examiner for R&D Systems Inc., with responsibility for 1 pending office action. As the only examiner assigned to the company's current workload, her specific feedback and examination history will be the primary drivers of the prosecution outcome.
The presence of 1 pending office action and 1 distinct examiner suggests a very focused intellectual property strategy at this time. Practitioners should focus on the specific nuances of the Biotechnology & Pharmaceuticals sector as they relate to the single active case. Because SWIFT, CANDICE LEE is the sole point of contact, understanding his specific preferences is essential for resolving the 1 pending office action efficiently.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SWIFT, CANDICE LEE | 1 | 57.5% | +36.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18000634 | ENHANCED hAT FAMILY MEMBER SPIN TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS | SWIFT, CANDICE LEE | 43d |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18000634 | ENHANCED hAT FAMILY MEMBER SPIN TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS | SWIFT, CANDICE LEE | 1657 | §112 | Final Rejection | 43d | Pending | Nov 01, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial